| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.0072 | 1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.0091 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |